Nanoceria as a possible agent for the management of COVID-19

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta, Daniel F. McAuley, Michael Brown et al. · The Lancet · 2020 · 10.2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Jonathan Grein, Norio Ohmagari, Daniel D. Shin et al. · New England Journal of Medicine · 2020 · 2.9K citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +12

Developing Covid-19 Vaccines at Pandemic Speed

Nicole Lurie, Mélanie Saville, Richard Hatchett et al. · New England Journal of Medicine · 2020 · 1.7K citations

Veterinary Medicine, Immunology, Infectious Diseases +17

TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes

Lynn Sanford, Ilona Ormsby, Adriana C. Gittenberger–de Groot et al. · Development · 1997 · 1.4K citations · Full text

Life Sciences, Developmental Biology, Molecular Genetics +17

Nanoceria exhibit redox state-dependent catalase mimetic activity

Talib Pirmohamed, Janet M. Dowding, Sanjay Singh et al. · Chemical Communications · 2010 · 1.2K citations · Full text

Natural Sciences, Chemistry, Materials Science +16